Is Eli Lilly overpriced?

Overall, the stock of Eli Lilly and Co (NYSE:LLY, 30-year Financials) appears to be significantly overvalued. The company’s financial condition is fair and its profitability is strong. Its growth ranks better than 85% of the companies in Drug Manufacturers industry.Jun 9, 2021

Leave a Comment